Biotechnology Innovation Organization (BIO)

Advocacy: Biotechnology Innovation Organization (bio)'s advocacy efforts reflect the priorities identified by the bio board of directors and the four section governing boards.the board of directors focuses on issues of importance to all bio members, regardless of their size or technology. These cross-cutting advocacy accomplishments in 2017 are listed below: - safeguarded and advanced intellectual property protections, domestically and internationally.- fostered a dialogue about bioethics and proactively advanced the socially responsible use of Biotechnology.- promoted investment in government and academic research.- expanded outreach to foreign governments and international entities to educate on policy issues of importance to the Biotechnology industry and to improve the investment and regulatory climate for biotech products.the health section 2018 advocacy accomplishments: - promoted healthcare policies that recognize both the promise and value of Innovation.- advocated for a safe and predictable regulatory environment for value-based payment arrangements for drugs and biologics.- enhanced and protected patient access ...

Services: bio's services include conferences and activities that bring together industry stakeholders and investors for events ranging from the bio international convention to conferences for business development executives. The bio international convention attracts approximately 16,000 of the most influential biotech and pharma attendees from 76 countries and 48 u.s. states, as well as the district of columbia, puerto rico and the us virgin islands, including 300 members of the media, and offers three days of professional and business development opportunities. The net income from the convention supports our advocacy, public outreach, and other member service activities. The key elements of the bio international convention are educational programming, exhibition, the bio business forum, and networking events. These elements provide an opportunity for Biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to learn about recent scientific and policy developments, and schedule one-on-one meetings to discuss potential business ...